December 2022

CONTENTS: Clinical Trial Accrual in South Dakota (2013-2020) | Clinical Trial Accrual in South Dakota (2013-2020) | Suicide Data Updates and Available Resources | 2021 HIV Surveillance Report

Clinical Trial Accrual in South Dakota
(2013-2020)

The enrollment of cancer patients into clinical trial studies is crucial for the development of new cancer treatments and advancements in cancer prevention. Cancer-related clinical research study categories include treatment trials, prevention, screening, and quality-of-life/supportive care/palliative care trials, among others.¹ Priority 10 of the 2021-2025 South Dakota Cancer Plan aims to increase participation of South Dakota (SD) cancer patients in cancer clinical trials. To measure progress, the SD Cancer Coalition partnered with the South Dakota Cancer Registry (SDCR) to determine the current clinical trial accrual rate within South Dakota using a reporting collection template that aligns with Commission on Cancer Standard 1.9: Clinical Research Accrual² to streamline reporting efforts for the cancer treatment centers. Reporting measures included the annual analytic caseload, total number of patients accrued as well as accrual by trial type, and the locations for each trial type (onsite and/or referred). The SDCR utilized this template to request data from the eight cancer treatment centers within the state. Since 2015, the cancer treatment centers have voluntarily reported their data annually to the SDCR. The SDCR assured the hospital-based cancer registries that the reporting was voluntary, and that individual hospital-based data would be held in confidence, with only aggregate data shared. The first report, published in Fall 2019, included data for calendar years 2013 to 2016. This report features data from 2017 to 2020 in addition to the previous years. All eight cancer treatment centers reported the data for a 100% response rate. In addition, an interactive dashboard was created and published on the Cancer Coalition website.

A summary of the findings presented in the dashboard is described in the article.

Cancer Survivorship in South Dakota

• 7.8% of survey respondents reported being diagnosed with cancer, and of those, 18.1% reported having two or more types of cancer 
• 48.5% of survivors received their first cancer diagnosis between the ages of
  40-64
• Breast cancer was the most prevalent cancer type (21.1%), followed by male reproductive cancers (18.1%), gastrointestinal cancers (12.3%), and female reproductive cancers (11.3%)
• Survivors had a higher prevalence of self-reported fair or poor health than those with no cancer history (31.6% vs. 12.4%)
• Survivors had a higher prevalence of being physically unhealthy for 14 or more days in the past 30 days than those with no cancer history (20.3% vs. 8.3%) 

Suicide Data Updates and
Available Resources

2022 HIV/AIDS Surveillance Report